SEC Form 4 · accession 0001209191-16-089766
Akebia Therapeutics, Inc. · AKBA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicole R. Hadas
Officer — SVP, General Counsel, Sec.
Period of report
Jan 1, 2016
Accepted (ET)
Jan 6, 2016 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001517022
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jan 4, 2016 | S | 1,811 | $12.28 | D | 64,584 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F172,623 shares of restricted stock (as adjusted from 41,499 shares prior to the 1.75-for-1 stock split effected on March 6, 2014) were awarded on December 23, 2013. Twenty-five percent of the shares vested on December 2, 2014. The remaining shares vest in equal quarterly installments over the following three years until fully vested.
- F2Shares sold by reporting person to pay taxes in connection with the vesting of restricted stock pursuant to the December 23, 2013 award described in footnote 1.
- F3The total amount of beneficial securities owned includes 1,135 shares of stock purchased on December 31, 2015 at $8.27 per share in connection with the Issuer's Employee Stock Purchase Plan.